Effectiveness and Safety of Bulkamid® as Bulking Agent for the Treatment of Female Urinary Incontinence

Effectiveness and Safety of Bulkamid® as Bulking Agent for the Treatment of Female Urinary Incontinence

To assess effectiveness of Bulkamid® injection in females suffering from stress or mixed (stress and urge) urinary incontinence after 12 months follow up period

Inclusion Criteria:

• Informed consent
• Symptomatic stress or mixed urinary incontinence for at least 12 months
• Having at least 1 incontinence episode per day over three days

Exclusion Criteria:

• Regular or intermittent users of an urethral catheter
• Pregnant women
• Suffer from severe allergies or anaphylaxis
• Suffer from autoimmune diseases or any unstable or sever cardio-vascular disease
• History of any cancer within the last 5 years
• Previous surgery for the treatment of urinary incontinence, including bulking